Mackenzie Financial Corp Bristol Myers Squibb CO Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mackenzie Financial Corp holds 317,923 shares of BMY stock, worth $18.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

317,923

Previous 505,654 37.13%

Holding current value

$18.4 Million

Previous $21 Million 21.65%

% of portfolio

0.02%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $7.45 Million - $9.72 Million	-187,731 Reduced 37.13%	317,923 $16.5 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $3.12 Million - $4.11 Million	-77,522 Reduced 13.29%	505,654 $21 Million
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $1.37 Million - $1.55 Million	-28,538 Reduced 4.67%	583,176 $31.6 Million
Q4 2023 Jan 30, 2024	BUY	$48.48 - $57.85 $8.15 Million - $9.73 Million	168,135 Added 37.9%	611,714 $31.4 Million
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $1.86 Million - $2.08 Million	-32,094 Reduced 6.75%	443,579 $25.7 Million
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $13.4 Million - $14.9 Million	-210,116 Reduced 30.64%	475,673 $30.4 Million
Q1 2023 Apr 24, 2023	BUY	$65.71 - $74.53 $1.47 Million - $1.67 Million	22,421 Added 3.38%	685,789 $47.5 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $2.62 Million - $3.1 Million	-38,250 Reduced 5.45%	663,368 $47.7 Million
Q3 2022 Oct 07, 2022	BUY	$0.13 - $76.84 $5,792 - $3.42 Million	44,558 Added 6.78%	701,618 $49.9 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $23.1 Million - $25.5 Million	318,497 Added 94.07%	657,060 $50.6 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $4.18 Million - $5.01 Million	68,018 Added 25.14%	338,563 $24.7 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $2.99 Million - $3.49 Million	-55,758 Reduced 17.09%	270,545 $16.9 Million
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $2.61 Million - $3.05 Million	44,067 Added 15.61%	326,303 $19.3 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $1.55 Million - $1.69 Million	24,998 Added 9.72%	282,236 $18.9 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $4.03 Million - $4.53 Million	67,916 Added 35.87%	257,238 $16.2 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $120,330 - $136,356	-2,084 Reduced 1.09%	189,322 $11.7 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $8,269 - $9,164	-144 Reduced 0.08%	191,406 $11.5 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $3.35 Million - $3.92 Million	-61,176 Reduced 24.21%	191,550 $11.3 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $6.91 Million - $10 Million	148,977 Added 143.59%	252,726 $14.1 Million
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $7.72 Million - $10.1 Million	-156,928 Reduced 60.2%	103,749 $6.66 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $50,725 - $60,142	-1,186 Reduced 0.45%	260,677 $13.2 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $1.39 Million - $1.53 Million	31,096 Added 13.48%	261,863 $11.9 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $176,419 - $210,358	3,910 Added 1.72%	230,767 $11 Million
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $5.07 Million - $6.58 Million	103,988 Added 84.63%	226,857 $11.8 Million
Q3 2018 Nov 15, 2018	BUY	$55.19 - $62.25 $1.3 Million - $1.47 Million	23,543 Added 23.7%	122,869 $7.63 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $869,823 - $1.08 Million	17,214 Added 20.96%	99,326 $5.5 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $3.48 Million - $4.01 Million	58,098 Added 241.93%	82,112 $5.19 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $4.5 Million - $4.9 Million	-75,041 Reduced 75.76%	24,014 $1.47 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $716,885 - $827,345	12,980 Added 15.08%	99,055 $6.31 Million
Q2 2017 Aug 14, 2017	BUY	N/A	86,075	86,075 $4.8 Million

Others Institutions Holding BMY

# of Institutions

2,532

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Bristol Myers Squibb CO Transaction History